Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.
Identifieur interne : 000D25 ( PubMed/Checkpoint ); précédent : 000D24; suivant : 000D26Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.
Auteurs : Taryn Vian [États-Unis] ; Sayaka Koseki ; Frank G. Feeley ; Jennifer BeardSource :
- BMC health services research [ 1472-6963 ] ; 2013.
Descripteurs français
- KwdFr :
- Afrique subsaharienne, Bourses d'études et bourses universitaires (organisation et administration), Coopération internationale, Essais cliniques comme sujet (), Humains, Infections à VIH (), Recherche biomédicale (organisation et administration), Renforcement des capacités (organisation et administration), Vaccins contre le SIDA.
- MESH :
English descriptors
- KwdEn :
- AIDS Vaccines, Africa South of the Sahara, Biomedical Research (organization & administration), Capacity Building (organization & administration), Clinical Trials as Topic (methods), Fellowships and Scholarships (organization & administration), HIV Infections (prevention & control), Humans, International Cooperation.
- MESH :
- chemical : AIDS Vaccines.
- geographic : Africa South of the Sahara.
- methods : Clinical Trials as Topic.
- organization & administration : Biomedical Research, Capacity Building, Fellowships and Scholarships.
- prevention & control : HIV Infections.
- Humans, International Cooperation.
Abstract
Industry partnerships can help leverage resources to advance HIV/AIDS vaccine research, service delivery, and policy advocacy goals. This often involves capacity building for international and local non-governmental organizations (NGOs). International volunteering is increasingly being used as a capacity building strategy, yet little is known about how corporate volunteers help to improve performance of NGOs in the fight against HIV/AIDS.
DOI: 10.1186/1472-6963-13-378
PubMed: 24088300
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24088300Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.</title><author><name sortKey="Vian, Taryn" sort="Vian, Taryn" uniqKey="Vian T" first="Taryn" last="Vian">Taryn Vian</name><affiliation wicri:level="2"><nlm:affiliation>Center for Global Health and Development, Boston University, 801 Massachusetts Avenue, Boston, MA 02118, USA. tvian@bu.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Global Health and Development, Boston University, 801 Massachusetts Avenue, Boston, MA 02118</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Koseki, Sayaka" sort="Koseki, Sayaka" uniqKey="Koseki S" first="Sayaka" last="Koseki">Sayaka Koseki</name></author><author><name sortKey="Feeley, Frank G" sort="Feeley, Frank G" uniqKey="Feeley F" first="Frank G" last="Feeley">Frank G. Feeley</name></author><author><name sortKey="Beard, Jennifer" sort="Beard, Jennifer" uniqKey="Beard J" first="Jennifer" last="Beard">Jennifer Beard</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24088300</idno><idno type="pmid">24088300</idno><idno type="doi">10.1186/1472-6963-13-378</idno><idno type="wicri:Area/PubMed/Corpus">001477</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001477</idno><idno type="wicri:Area/PubMed/Curation">001477</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001477</idno><idno type="wicri:Area/PubMed/Checkpoint">001477</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001477</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.</title><author><name sortKey="Vian, Taryn" sort="Vian, Taryn" uniqKey="Vian T" first="Taryn" last="Vian">Taryn Vian</name><affiliation wicri:level="2"><nlm:affiliation>Center for Global Health and Development, Boston University, 801 Massachusetts Avenue, Boston, MA 02118, USA. tvian@bu.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Global Health and Development, Boston University, 801 Massachusetts Avenue, Boston, MA 02118</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Koseki, Sayaka" sort="Koseki, Sayaka" uniqKey="Koseki S" first="Sayaka" last="Koseki">Sayaka Koseki</name></author><author><name sortKey="Feeley, Frank G" sort="Feeley, Frank G" uniqKey="Feeley F" first="Frank G" last="Feeley">Frank G. Feeley</name></author><author><name sortKey="Beard, Jennifer" sort="Beard, Jennifer" uniqKey="Beard J" first="Jennifer" last="Beard">Jennifer Beard</name></author></analytic><series><title level="j">BMC health services research</title><idno type="eISSN">1472-6963</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Vaccines</term><term>Africa South of the Sahara</term><term>Biomedical Research (organization & administration)</term><term>Capacity Building (organization & administration)</term><term>Clinical Trials as Topic (methods)</term><term>Fellowships and Scholarships (organization & administration)</term><term>HIV Infections (prevention & control)</term><term>Humans</term><term>International Cooperation</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique subsaharienne</term><term>Bourses d'études et bourses universitaires (organisation et administration)</term><term>Coopération internationale</term><term>Essais cliniques comme sujet ()</term><term>Humains</term><term>Infections à VIH ()</term><term>Recherche biomédicale (organisation et administration)</term><term>Renforcement des capacités (organisation et administration)</term><term>Vaccins contre le SIDA</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>AIDS Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa South of the Sahara</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Trials as Topic</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Bourses d'études et bourses universitaires</term><term>Recherche biomédicale</term><term>Renforcement des capacités</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Biomedical Research</term><term>Capacity Building</term><term>Fellowships and Scholarships</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>International Cooperation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Afrique subsaharienne</term><term>Coopération internationale</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Infections à VIH</term><term>Vaccins contre le SIDA</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Industry partnerships can help leverage resources to advance HIV/AIDS vaccine research, service delivery, and policy advocacy goals. This often involves capacity building for international and local non-governmental organizations (NGOs). International volunteering is increasingly being used as a capacity building strategy, yet little is known about how corporate volunteers help to improve performance of NGOs in the fight against HIV/AIDS.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24088300</PMID><DateCreated><Year>2013</Year><Month>11</Month><Day>15</Day></DateCreated><DateCompleted><Year>2014</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2013</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.</ArticleTitle><Pagination><MedlinePgn>378</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1472-6963-13-378</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Industry partnerships can help leverage resources to advance HIV/AIDS vaccine research, service delivery, and policy advocacy goals. This often involves capacity building for international and local non-governmental organizations (NGOs). International volunteering is increasingly being used as a capacity building strategy, yet little is known about how corporate volunteers help to improve performance of NGOs in the fight against HIV/AIDS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This case study helps to extend our understanding by analyzing how the Pfizer Global Health Fellows (GHF) program helped develop capacity of the International AIDS Vaccine Initiative (IAVI), looking specifically at Fellowship activities in South Africa, Kenya, and Uganda. From 2005-2009, 8 Pfizer GHF worked with IAVI and local research centers to strengthen capacity to conduct and monitor vaccine trials to meet international standards and expand trial activities. Data collection for the case study included review of Fellow job descriptions, online journals, evaluation reports, and interviews with Fellows and IAVI staff. Qualitative methods were used to analyze factors which influenced the process and outcomes of capacity strengthening.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fellows filled critical short-term expert staffing needs at IAVI as well as providing technical assistance and staff development activities. Capacity building included assistance in establishing operating procedures for the start-up period of research centers; training staff in Good Clinical Practice (GCP); developing monitoring capacity (staff and systems) to assure that centers are audit-ready at all times; and strategic planning for data management systems. Factors key to the success of volunteering partnerships included similarities in mission between the corporate and NGO partners, expertise and experience of Fellows, and attitudes of partner organization staff.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">By developing standard operating procedures, ensuring that monitoring and regulatory compliance systems were in place, training African investigators and community members, and engaging in other systems strengthening activities, the GHF program helped IAVI to accelerate vaccine development activities in the field, and to develop the organization's capacity to manage change in the future. Our study suggests that a program of sustained corporate volunteering over several years may increase organizational learning and trust, leading to stronger capacity to advance and achieve NGO goals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vian</LastName><ForeName>Taryn</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Global Health and Development, Boston University, 801 Massachusetts Avenue, Boston, MA 02118, USA. tvian@bu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koseki</LastName><ForeName>Sayaka</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Feeley</LastName><ForeName>Frank G</ForeName><Initials>FG</Initials></Author><Author ValidYN="Y"><LastName>Beard</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nurs Res Pract. 2013;2013:709025</RefSource><PMID Version="1">23956854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Public Health. 2012;12:531</RefSource><PMID Version="1">22818046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Res Policy Syst. 2008 Aug 01;6:8</RefSource><PMID Version="1">18673541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Fam Pract. 2005 Oct 27;6:44</RefSource><PMID Version="1">16253133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Promot Int. 2008 Sep;23(3):251-9</RefSource><PMID Version="1">18407925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Policy. 1997 Jan;39(1):29-42</RefSource><PMID Version="1">10164903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2000;78(5):699-709</RefSource><PMID Version="1">10859865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Health Plann Manage. 2002 Jan-Mar;17(1):3-22</RefSource><PMID Version="1">11963442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Res Policy Syst. 2011;9:44</RefSource><PMID Version="1">22206247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glob Health Action. 2012;5:18369</RefSource><PMID Version="1">22761602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Resour Health. 2007 Mar 02;5:8</RefSource><PMID Version="1">17335578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Health Plann Manage. 2011 Apr-Jun;26(2):e85-101</RefSource><PMID Version="1">20556742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Policy Plan. 2014 Aug;29(5):560-9</RefSource><PMID Version="1">23962441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Res Policy Syst. 2013;11:14</RefSource><PMID Version="1">23618363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Pharmacol Ther. 2013 Jun;93(6):468-70</RefSource><PMID Version="1">23689211</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016915" MajorTopicYN="Y">AIDS Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057191" MajorTopicYN="N">Capacity Building</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005257" MajorTopicYN="N">Fellowships and Scholarships</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3851536</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24088300</ArticleId><ArticleId IdType="pii">1472-6963-13-378</ArticleId><ArticleId IdType="doi">10.1186/1472-6963-13-378</ArticleId><ArticleId IdType="pmc">PMC3851536</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><noCountry><name sortKey="Beard, Jennifer" sort="Beard, Jennifer" uniqKey="Beard J" first="Jennifer" last="Beard">Jennifer Beard</name><name sortKey="Feeley, Frank G" sort="Feeley, Frank G" uniqKey="Feeley F" first="Frank G" last="Feeley">Frank G. Feeley</name><name sortKey="Koseki, Sayaka" sort="Koseki, Sayaka" uniqKey="Koseki S" first="Sayaka" last="Koseki">Sayaka Koseki</name></noCountry><country name="États-Unis"><region name="Massachusetts"><name sortKey="Vian, Taryn" sort="Vian, Taryn" uniqKey="Vian T" first="Taryn" last="Vian">Taryn Vian</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000D25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24088300
|texte= Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows program and the International AIDS Vaccine Initiative.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24088300" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |